The depression of immune responses during measles infection has been recognized since the early 20th century. Acute bacterial infections are the most common cause of morbidity and mortality in measles. This study investigated the phagocytic and bactericidal or fungicidal capacities of polymorphonuclear cells (PMN) and monocytes during measles infections. When 14 children with measles were compared with 25 healthy controls, a significant depression in PMN and monocyte function was found. Of these 14 children, seven developed acute bacterial infections. These seven children were compared with 11 children who had acute bacterial infections without measles. It was found that PMN in patients with measles did not achieve an activated state, as expected with acute infections. Serum immunoglobulins were not altered in these patients. These results confirm previous reports of depressed phagocytic and bactericial capacities of PMN in measles, and further document that peripheral blood monocyte functions are also depressed in measles.
Background and Rationale:Ensuring research participants’ autonomy is one of the core ethical obligations of researchers. This fundamental principle confers on every participant the right to refuse to take part in clinical research, and the measure of the number of consent refusals could be an important metric to evaluate the quality of the informed consent process. This audit examined consent refusals among Indian participants in clinical studies done at our center.Materials and Methods:The number of consent refusals and their reasons in 10 studies done at our center over a 5-year period were assessed. The studies were classified by the authors according to the type of participant (healthy vs patients), type of sponsor (investigator-initiated vs pharmaceutical industry), type of study (observational vs interventional), level of risk [based on the Indian Council of Medical Research (ICMR) “Ethical Guidelines for Biomedical Research on Human Participants”], available knowledge of the intervention being studied, and each patient's disease condition.Results:The overall consent refusal rate was 21%. This rate was higher among patient participants [23.8% vs. healthy people (14.9%); P = 0.002], in interventional studies [33.6% vs observational studies (7.5%); P < 0.0001], in pharmaceutical industry-sponsored studies [34.7% vs investigator-initiated studies (7.2%); P < 0.0001], and in studies with greater risk (P < 0.0001). The most common reasons for consent refusals were multiple blood collections (28%), inability to comply with the study protocol (20%), and the risks involved (20%).Conclusion:Our audit suggests the adequacy and reasonable quality of the informed consent process using consent refusals as a metric.
Acute necrotising pancreatitis is associated with an unacceptably high mortality for which no
satisfactory remedy exists. Emblica officinalis (E.o.) is a plant prescribed in Ayurveda, the
Indian traditional system of medicine, for pancreas-related disorders. This study was carried
out to evaluate the protective effect of E.o. against acute necrotising pancreatitis in dogs.
Pancreatitis was induced by injecting a mixture of trypsin, bile and blood into the duodenal
opening of the pancreatic duct. Twenty eight dogs were divided into 4 groups (n = 6-8 each):
GpI–control, GpII–acute pancreatitis, GpIII–sham-operated, GpIV–pretreatment with
28 mg E.o./kg/day for 15 days before inducing pancreatitis. Serum amylase increased from
541.99 ± 129.13 IU/ml to 1592.63 ± 327.83 IU (p<0.02) 2 hrs after the induction of pancreatitis
in GpII. The rise in serum amylase in both GpIII and GpIV was not significant. On
light microscopic examination, acinar cell damage was less and the total inflammatory score
was significantly lower in the E.o. treated group as compared to GpII. Electron microscopy
confirmed this and showed an increased amount of smooth, endoplasmic reticulum and small,
condensed granules embedded in a vacuole. More studies are needed to explore the clinical
potential of E.o. and its mechanism of action.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.